Related references
Note: Only part of the references are listed.Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea
Juneyoung Lee et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)
Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes
Eugene Han et al.
MEDICINE (2016)
The Relationship between 10-Year Cardiovascular Risk Calculated Using the Pooled Cohort Equation and the Severity of Non-Alcoholic Fatty Liver Disease
Jeong In Lee et al.
ENDOCRINOLOGY AND METABOLISM (2016)
Chronic HMGCR/HMG-CoA reductase inhibitor treatment contributes to dysglycemia by upregulating hepatic gluconeogenesis through autophagy induction
Hye Jin Wang et al.
AUTOPHAGY (2015)
Statin Use and Risk for Primary Liver Cancer in the Clinical Practice Research Datalink
Katherine A. McGlynn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Statin Use and Risk for Primary Liver Cancer in the Clinical Practice Research Datalink
Katherine A. McGlynn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies
Kohei Oda et al.
CLINICAL JOURNAL OF GASTROENTEROLOGY (2015)
Hepatocellular carcinoma epidemiology
Cristina Bosetti et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2014)
Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis
Robert Fleetcroft et al.
BMC HEALTH SERVICES RESEARCH (2014)
Use of Statins and the Risk of Death in Patients With Prostate Cancer
Oriana Yu et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Statin use and risk of liver cancer: an update meta-analysis
Meng Shi et al.
BMJ OPEN (2014)
Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study
Sune F. Nielsen et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Statin for the Primary Prevention of Cardiovascular Disease in Patients with Diabetes Mellitus
Bo Kyung Koo
DIABETES & METABOLISM JOURNAL (2014)
Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
Siddharth Singh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study
W-P Koh et al.
BRITISH JOURNAL OF CANCER (2013)
Statins and primary liver cancer: a meta-analysis of observational studies
Danitza Pradelli et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2013)
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
Hsiao-Ping Chen et al.
GUT (2013)
Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels
Matti J. Tikkanen et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
Yu-Tse Tsan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Prevalence and Management of Dyslipidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010
Eun Roh et al.
DIABETES & METABOLISM JOURNAL (2013)
The Influence of Diabetes in the Pathogenesis and the Clinical Course of Hepatocellular Carcinoma: Recent Findings and New Perspectives
Antonio Facciorusso
CURRENT DIABETES REVIEWS (2013)
Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy: A Population-Based Cohort Study
Shih-Wei Lai et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
Laurent Azoulay et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Association of Diabetes Duration and Diabetes Treatment With the Risk of Hepatocellular Carcinoma
Manal M. Hassan et al.
CANCER (2010)
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
Vasilios G. Athyros et al.
LANCET (2010)
Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2009)
Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review
Silvia Sookoian et al.
JOURNAL OF HEPATOLOGY (2008)
Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
Edward J. Mills et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes:: A histopathological follow-up study
Mattlas Ekstedt et al.
JOURNAL OF HEPATOLOGY (2007)
Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C
Giovanni Targher et al.
JOURNAL OF HEPATOLOGY (2007)
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
HD Quan et al.
MEDICAL CARE (2005)
Hepatocellular carcinoma: Epidemiology risk factors, and screening
M Sherman
SEMINARS IN LIVER DISEASE (2005)
Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study
JA Davila et al.
GUT (2005)
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
HB El-Serag et al.
GASTROENTEROLOGY (2004)
Primary liver cancer:: Worldwide incidence and trends
FX Bosch et al.
GASTROENTEROLOGY (2004)
The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update
H El-Serag et al.
ANNALS OF INTERNAL MEDICINE (2003)
3-hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway: Implications for diabetic nephropathy
FR Danesh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis
WWL Wong et al.
LEUKEMIA (2002)
Statins: mechanism of action and effects
C Stancu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2001)
Share Paper
